This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Probiocon Gmbh. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: The Innovations of Hans-Georg Kopp
Introduction
Hans-Georg Kopp is a notable inventor based in Metzingen, Germany. He has made significant contributions to the field of medical research, particularly in cancer treatment. With a total of 2 patents, Kopp's work focuses on innovative solutions to combat metastatic diseases.
Latest Patents
Kopp's latest patents include a RANKL-specific agent for treating metastatic disease. This invention provides a RANKL-specific antagonistic agent that recognizes human platelet-expressed receptor activator of nuclear factor kappa-B ligand (pRANKL). It is designed for use in treating cancer patients to prevent or reduce premetastatic lesions in the blood. This groundbreaking approach aims to improve the quality of life for those affected by cancer.
Career Highlights
Throughout his career, Hans-Georg Kopp has been associated with Probiocon GmbH, where he has been able to apply his expertise in developing innovative medical solutions. His work has garnered attention in the scientific community, contributing to advancements in cancer treatment.
Collaborations
Kopp has collaborated with esteemed colleagues such as Helmut Salih and Ludger Grosse-Hovest. These partnerships have further enhanced the impact of his research and innovations in the medical field.
Conclusion
Hans-Georg Kopp's contributions to cancer treatment through his innovative patents highlight the importance of research and collaboration in the medical field. His work continues to inspire advancements that may lead to better outcomes for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile